Zomedica Corp. Balance Sheet
ZOMDF|6 years of annual SEC 10-K data (FY2020-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
Zomedica Corp. had $127M in total assets and $115M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.0M | $7.0M | $13.0M | $27.4M | $195.0M | $62.0M |
| Accounts Receivable | $3.0M | $2.4M | $1.2M | $596.0K | - | $146.2K |
| Inventory | $5.5M | $5.1M | $5.1M | $2.7M | $2.8M | - |
| Current Assets | $64.0M | $81.8M | $99.9M | $123.5M | $200.4M | $62.9M |
| PP&E (Net) | $20.9M | $24.6M | $10.3M | $6.8M | $1.2M | $583.0K |
| Goodwill | $0 | $45.6M | $61.6M | $64.0M | $43.3M | - |
| Total Assets | $127.0M | $207.4M | $253.2M | $279.6M | $280.4M | $66.1M |
| Current Liabilities | $9.4M | $9.3M | $9.0M | $7.8M | $4.3M | $2.0M |
| Total Debt | - | - | - | - | - | $527.4K |
| Shareholders' Equity | $115.4M | $195.7M | $240.0M | $267.4M | $270.9M | $51.1M |